6533b827fe1ef96bd1285c6d

RESEARCH PRODUCT

The randomized shortened dental arch study: tooth loss.

Matthias KernSinsa HartmannAnke WeberV KleinPeter PospiechStefan WolfartBirgit MarréJoachim GerssA. LudwigE. BuscheWolfgang HannakKlaus BöningBernd WöstmannMichael H. WalterGuido HeydeckeTorsten MundtM StumbaumRalph G. LuthardtJ. HuppertzI GittFlorentine Jahn

subject

MolarMaleRandomizationmedicine.medical_treatmentDentistryKaplan-Meier Estimatelaw.inventionTooth LossDental Archstomatognathic systemRandomized controlled triallawOral and maxillofacial pathologyTooth lossMedicineHumansGeneral DentistryOrthodonticsbusiness.industryDental prosthesisMiddle Agedmedicine.diseaseMolarDental archmedicine.anatomical_structureDenture Partial RemovableFemalemedicine.symptombusinessProsthodontics

description

The evidence concerning the management of shortened dental arch (SDA) cases is sparse. This multi-center study was aimed at generating data on outcomes and survival rates for two common treatments, removable dental prostheses (RDP) for molar replacement or no replacement (SDA). The hypothesis was that the treatments lead to different incidences of tooth loss. We included 215 patients with complete molar loss in one jaw. Molars were either replaced by RDP or not replaced, according to the SDA concept. First tooth loss after treatment was the primary outcome measure. This event occurred in 13 patients in the RDP group and nine patients in the SDA group. The respective Kaplan-Meier survival rates at 38 months were 0.83 (95% CI: 0.74-0.91) in the RDP group and 0.86 (95% CI: 0.78-0.95) in the SDA group, the difference being non-significant.

10.1177/0022034510366817https://pubmed.ncbi.nlm.nih.gov/21605837